Kintsugi Voice is an API-first platform, we are developing novel voice biomarker infrastructure to detect signs of clinical depression and anxiety from short clips of free form speech. We help healthcare organizations scale access to mental healthcare with smarter, more accurate triage. Our technology supports multiple use-cases to help more people get the right care at the right time.  We focus on early detection that allows you to lower cost and improve patient outcomes. We have created the first clinical-grade voice biomarker diagnostic (U.S. Patent-Pending and FDA De Novo pending) to measure the severity of depression and anxiety in real-time.

Direct is the leading EHR-integrated cost transparency solution. The solution brings real-time, pharmacy benefit cost information, coverage restrictions, and alternatives into native EHR workflows. Giving providers cost information at the point-of-care enables data-driven and evidence-based decisions that help patients get the care they need at prices they can afford.

Features and Benefits:

 - Access to lower-cost alternatives increases care adherence and patient health and satisfaction

 - Select medications that do not require prior authorization

 - Reduced pharmacy/PBM/payer call-backs, prior authorization denials, and other uncompensated provider hassles

 - Uses native order workflows, is easy to implement

- Surfaces pharmacy alternatives to drive continuity of care and patient satisfaction

- Integrates patient affordability program offerings into RTPB results, showing best-cost options when insurance coverage isn't found or doesn't apply. 

Arrive Health is a healthcare technology company dedicated to putting the needs of patients and providers first. We improve access to the most affordable, quality care by delivering accurate, patient-specific cost and coverage data to providers, care teams, and patients. Collaborating with premier health systems, pharmacy benefit managers, payers, and healthcare IT vendors, Arrive Health is clearing the way for better health by reducing friction in care workflows and enabling meaningful conversations about access to care. To learn more, please visit ArriveHealth.com.

1. Kintsugi Voice only needs 20 seconds of free from speech vs. a manual screen that takes roughly 10 minutes.
2. Kintsugi Voice is language agnostic and does not listen to what a patient is saying, but how they are saying it.
3. Kintsugi has the largest annotated patient data model, validated by a psychiatrist team with more than 7 years experience. This allows us to predict depression and anxiety with high specificity and severity, based off of PHQ-9 standards.
4. Kintsugi Voice’s flexible API enables hundreds of workflows from retrospective to live in-call scoring. Typical depression screenings are typically delivered 1 time and not longitudinal. We provide the ability to longitudinally track patients across a period of time.

1. We are not a NLP tool, we do not need any canned speech and or paragraph read to detect depression and or anxiety.
2. We have the largest annotated data model in the world with over 35k patients.
3. We are supporting over 1M at risk lives.
4. 2X accuracy rating compared to the standard of care.

Our solution is seamlessly embedded into EHR workflows, allowing for direct connections to payer and PBM source-of-truth data. EHRs typically allow for one or many connections to Real-Time Prescription Benefit solutions, but rarely have their own prescription price transparency capabilities built-in. 

Arrive Health delivers the industry's most accurate, patient-specific cost and coverage information to the EHR. Many providers do not trust the pricing information displayed in their workflow because of its obsolete or incorrect nature (see whitepaper below). However, Arrive Health delivers data that providers can rely on, taking into consideration up-to-date copay and deductible information, benefit details, and preferred locations. We also display therapeutic alternatives that are covered under the patient's insurance, options that might not require prior authorization, and options at a health system's own internal pharmacy.